NCT05574374View on ClinicalTrials.gov

Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

March 6, 2023

Study Completion Date

March 6, 2023

Conditions
Drug Drug Interaction
Interventions
DRUG

DWP14012

Potassium-competitive acid blocker

DRUG

DWC202202

Clopidogrel Bisulfate

DRUG

DWC202203

Proton pump inhibitor

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT05574374 - Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects | Biotech Hunter | Biotech Hunter